| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 438 |
| 1 | IBRUTINIB | 260 |
| 2 | ADALIMUMAB | 191 |
| 3 | PREDNISONE | 190 |
| 4 | ACETAMINOPHEN | 167 |
| 5 | ERGOCALCIFEROL | 159 |
| 6 | FINGOLIMOD HCL | 148 |
| 7 | METHOTREXATE SODIUM | 148 |
| 8 | METHOTREXATE | 125 |
| 9 | ACETAMINOPHEN 500MG | 123 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CILTACABTAGENE AUTOLEUCEL | 50 | 0.0076 |
| 1 | ERGOCALCIFEROL | 159 | 0.0053 |
| 2 | CLOZAPINE | 438 | 0.0035 |
| 3 | IBRUTINIB | 260 | 0.0032 |
| 4 | OBINUTUZUMAB | 50 | 0.0030 |
| 5 | GOLIMUMAB | 27 | 0.0021 |
| 6 | VALPROATE SODIUM | 43 | 0.0020 |
| 7 | FINGOLIMOD HCL | 148 | 0.0017 |
| 8 | VENETOCLAX | 97 | 0.0015 |
| 9 | RIBOCICLIB | 48 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 543 |
| 1 | Kinase Inhibitor [EPC] | 413 |
| 2 | Corticosteroid [EPC] | 386 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 357 |
| 4 | Benzodiazepine [EPC] | 229 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 228 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 194 |
| 7 | Vitamin C [EPC] | 160 |
| 8 | Provitamin D2 Compound [EPC] | 159 |
| 9 | Proton Pump Inhibitor [EPC] | 147 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cyclooxygenase Inhibitor [EPC] | 1 | 0.0122 |
| 1 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 2 | Provitamin D2 Compound [EPC] | 159 | 0.0053 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 8 | 0.0039 |
| 4 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 15 | 0.0025 |
| 5 | Plasma Volume Expander [EPC] | 7 | 0.0023 |
| 6 | Adrenocorticotropic Hormone [EPC] | 2 | 0.0022 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 13 | 0.0022 |
| 8 | Dopamine-2 Receptor Antagonist [EPC] | 14 | 0.0018 |
| 9 | BCL-2 Inhibitor [EPC] | 97 | 0.0015 |